APA (7th ed.) Citation

Huang, Y., Tsou, M., Li, P., Chen, J., Liu, Y., Meyerowitz‐Katz, G., . . . Su, P. (2026). Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: A Target‐Trial Emulation. Advanced Science, 13(11), 1. https://doi.org/10.1002/advs.202518813

Chicago Style (17th ed.) Citation

Huang, Yu‐Nan, Min‐Yu Tsou, Pin‐Hung Li, Jo‐Ching Chen, Yen‐Liang Liu, Gideon Meyerowitz‐Katz, Tsung‐Hsun Tsai, and Pen‐Hua Su. "Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: A Target‐Trial Emulation." Advanced Science 13, no. 11 (2026): 1. https://doi.org/10.1002/advs.202518813.

MLA (9th ed.) Citation

Huang, Yu‐Nan, et al. "Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: A Target‐Trial Emulation." Advanced Science, vol. 13, no. 11, 2026, p. 1, https://doi.org/10.1002/advs.202518813.